Longaeva Partners’s Obsidian Therapeutics OBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.63M Buy
+499,963
New +$9.8M 0.14% 161

Other funds holding OBX

Longaeva Partners's OBX Position: Q3 2026 in Review

Longaeva Partners opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 499,963 shares worth $6.63M. The stake represents 0.14% of the portfolio and ranks #161 among its holdings.

60 funds tracked by Wall St. Rank hold OBX as of Q3 2026.

  • Longaeva Partners held 499,963 shares of Obsidian Therapeutics worth $6.63M as of Q3 2026.
  • Obsidian Therapeutics was a new Longaeva Partners position in Q3 2026.
  • Obsidian Therapeutics made up 0.14% of Longaeva Partners's portfolio in Q3 2026, its #161 holding.
  • 60 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.

Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.